PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31816863-6	2019	RESULTS: Celecoxib reduced cell growth and induced apoptosis through AKT blockade, cleavage of poly (ADP-ribose) polymerase-1 (PARP-1), and proteasomal degradation of the anti-apoptotic protein Mcl-1.	celecoxib	9-18	AKT serine/threonine kinase 1	Homo sapiens	69-72	
31816863-6	2019	RESULTS: Celecoxib reduced cell growth and induced apoptosis through AKT blockade, cleavage of poly (ADP-ribose) polymerase-1 (PARP-1), and proteasomal degradation of the anti-apoptotic protein Mcl-1.	celecoxib	9-18	poly(ADP-ribose) polymerase 1	Homo sapiens	95-125	
31816863-6	2019	RESULTS: Celecoxib reduced cell growth and induced apoptosis through AKT blockade, cleavage of poly (ADP-ribose) polymerase-1 (PARP-1), and proteasomal degradation of the anti-apoptotic protein Mcl-1.	celecoxib	9-18	poly(ADP-ribose) polymerase 1	Homo sapiens	127-133	
31816863-6	2019	RESULTS: Celecoxib reduced cell growth and induced apoptosis through AKT blockade, cleavage of poly (ADP-ribose) polymerase-1 (PARP-1), and proteasomal degradation of the anti-apoptotic protein Mcl-1.	celecoxib	9-18	MCL1 apoptosis regulator, BCL2 family member	Homo sapiens	194-199	
31816863-8	2019	Celecoxib reduced the invasive phenotype of CRPC cells by modulating NF-kappaB activity and reduced tumor growth in mice xenografts when administered in association with the anti-EGFR receptor antibody cetuximab.	celecoxib	0-9	epidermal growth factor receptor	Mus musculus	179-183